Men Who Skip Prostate Screenings Face a 45% Higher Risk of Death
- Researchers warn that men who skip prostate cancer screenings are 45% more likely to die from the disease, according to UC San Francisco .
- Prostate cancer is the most common cancer among men and the second-leading cause of cancer deaths, according to UC San Francisco .
- Researchers stated that men who attend screenings have a 23% lower risk of dying from prostate cancer compared to a control group.
- Dr. Leenen emphasized the need to understand why some men avoid screenings and how to encourage their participation to improve outcomes.
22 Articles
22 Articles
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Distinct translocation mechanisms and additional translocation partners for ETS genes are found in prostate cancer. This study also provides the first functional evidence that ETS gene deregulation can promote cancer cell invasion in cell lines and pre-malignant prostate lesions in a transgenic mouse model. Recently, we identified recurrent gene fusions involving the 5′ untranslated region of the androgen-regulated gene TMPRSS2 and the ETS (E26 …
Coverage Details
Bias Distribution
- 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage